Development and validation of a noninvasive score for at-risk metabolic dysfunction–associated steatohepatitis in individuals with obesity undergoing bariatric surgery
The FMO is an accurate and cost-effective noninvasive score for at-risk MASH identification in populations with obesity.
Authors
- Teng Liu (ORCID: https://orcid.org/0009-0007-2263-4767)
- Xuehui Chu
- Shaozhuang Liu (ORCID: https://orcid.org/0000-0003-2052-0516)
- Shibo Lin (ORCID: https://orcid.org/0000-0003-1839-3781)
- Zhiyong Dong (ORCID: https://orcid.org/0000-0002-6934-8043)
- Hao Bai (ORCID: https://orcid.org/0000-0002-5738-4186)
- Shumin Li (ORCID: https://orcid.org/0000-0002-3691-1098)
- Hui Liang (ORCID: https://orcid.org/0000-0001-6792-0811)
- Zehua Zhao (ORCID: https://orcid.org/0009-0000-3337-0102)
- Xitai Sun (ORCID: https://orcid.org/0000-0001-9679-0171)
- Tao Zhu (ORCID: https://orcid.org/0000-0002-6103-535X)
- Mingwei Zhong (ORCID: https://orcid.org/0000-0002-8235-3752)
- Xin Huang (ORCID: https://orcid.org/0000-0002-6208-4751)
- Liyong Chen (ORCID: https://orcid.org/0000-0003-1492-7125)
- Guangyong Zhang (ORCID: https://orcid.org/0000-0002-4122-9675)
Institutions
- Shandong University (CN)
- Nanjing Drum Tower Hospital (CN)
- Jiangsu Province Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- First Affiliated Hospital of Jinan University (CN)
- Shandong First Medical University (CN)
- State Key Laboratory of Reproductive Medicine
- Putian University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hepatology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1097/hep.0000000000001612
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00